Smith & Nephew acquires skin substitute for $660M (~5X sales)

Smith & Nephew buys skin substitute maker for $660M (MedTechDive)
Dive Brief:

Smith & Nephew announced Tuesday it has agreed to pay $660 million to acquire Osiris Therapeutics to expand its presence in the fast-growing regenerative medicine market. The company also announced it is acquiring Brainlab's orthopaedic joint reconstruction business in an effort to boost its digital surgery and robotic assets. 
Osiris sells products including skin, bone graft and cartilage substitutes, generating $102 million in revenue for the nine months ended September 2018, an...